Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

A Traunecker1, W Lüke, K Karjalainen

  • 1Basel Institute for Immunology, Switzerland.

Nature
|January 7, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of primary anal sphincter repair after obstetric injury and evaluation of a novel three-choice assessment.

Techniques in coloproctology·2018
Same author

Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.

The pharmacogenomics journal·2017
Same author

Intestinal CD103(+)CD11b(-) dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells.

Mucosal immunology·2015
Same author

Feasibility of minilaparotomy versus laparoscopic cholecystectomy for day surgery: a prospective randomised study.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2010
Same author

WITHDRAWN: Multidisciplinary bio-psycho-social rehabilitation for chronic low-back pain.

The Cochrane database of systematic reviews·2007
Same author

Multidisciplinary biopsychosocial rehabilitation for subacute low back pain among working age adults.

The Cochrane database of systematic reviews·2003

Soluble CD4 protein can block human immunodeficiency virus (HIV) infection by preventing the virus from attaching to helper T cells. This research demonstrates a potential new strategy for combating HIV by using engineered CD4 to inhibit viral entry.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Human immunodeficiency virus (HIV) targets helper T lymphocytes expressing CD4.
  • HIV evades immune responses by mutating, while still requiring CD4 for infection.
  • Blocking the interaction between HIV and CD4 is a potential therapeutic strategy.

Purpose of the Study:

  • To investigate the potential of soluble CD4 protein as an inhibitor of HIV infection.
  • To explore a novel route for blocking viral attachment to target cells.

Main Methods:

  • Utilized recombinant DNA techniques to create soluble forms of CD4 protein.
  • Tested the efficacy of soluble CD4 in inhibiting HIV infection in vitro.

Main Results:

Related Experiment Videos

  • Generated soluble CD4 protein using recombinant DNA technology.
  • Demonstrated that soluble CD4 is a potent inhibitor of HIV infection in laboratory settings.

Conclusions:

  • Soluble CD4 protein effectively inhibits HIV infection in vitro.
  • This approach offers a promising strategy for developing new anti-HIV therapies by blocking viral entry.